Forte Biosciences | 8-K: Current report
Forte Biosciences | SCHEDULE 13G: Others
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Wagner Paul A.
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Riley Antony A
Forte Biosciences | DEF 14A: Definitive information statements
Forte Biosciences | EFFECT: Others
Forte Biosciences | 424B3: Prospectus
Forte Biosciences | CORRESP: CORRESP
Forte Biosciences | UPLOAD: Others
Forte Biosciences | S-3: Registration statement for specified transactions by certain issuers
Forte Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alger Associates, Inc.(15.0%)
Forte Biosciences | 8-K: Current report
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Riley Antony A
Forte Biosciences | 8-K: Current report
Forte Biosciences | 8-K: FORTE BIOSCIENCES, INC. ANNOUNCES THIRD QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE
Forte Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alger Associates, Inc.(5.7%)
Forte Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(9.99%),Joseph Edelman(9.99%), etc.
Forte Biosciences | 10-Q: Q3 2024 Earnings Report
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Riley Antony A
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Wagner Paul A.